Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial (Q34515554)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial (English)

1 reference

Europe PubMed Central

2 August 2017

prevention of HIV/AIDS

0 references

tuberculosis in India

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Soumya Swaminathan

1

object named as

Soumya Swaminathan

0 references

author name string

Pradeep Aravindan Menon

2

1 reference

Europe PubMed Central

2 August 2017

Narendran Gopalan

3

1 reference

Europe PubMed Central

2 August 2017

Venkatesan Perumal

4

1 reference

Europe PubMed Central

2 August 2017

Ramesh Kumar Santhanakrishnan

5

1 reference

Europe PubMed Central

2 August 2017

Ranjani Ramachandran

6

1 reference

Europe PubMed Central

2 August 2017

Ponnuraja Chinnaiyan

7

1 reference

Europe PubMed Central

2 August 2017

Sheik Iliayas

8

1 reference

Europe PubMed Central

2 August 2017

Padmapriyadarsini Chandrasekaran

9

1 reference

Europe PubMed Central

2 August 2017

Pooranaganga Devi Navaneethapandian

10

1 reference

Europe PubMed Central

2 August 2017

Thiruvalluvan Elangovan

11

1 reference

Europe PubMed Central

2 August 2017

Mai Tuyet Pho

12

1 reference

Europe PubMed Central

2 August 2017

Fraser Wares

13

1 reference

Europe PubMed Central

2 August 2017

Narayanan Paranji Ramaiyengar

14

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

14 December 2012

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

7

1 reference

Europe PubMed Central

2 August 2017

12

1 reference

Europe PubMed Central

2 August 2017

e47400

1 reference

Europe PubMed Central

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

14 December 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

The HIV-associated tuberculosis epidemic--when will we act?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Isoniazid preventive therapy and risk for resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Tuberculosis epidemiology in India: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Detecting selection bias in randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Natural history and spectrum of disease in adults with HIV/AIDS in Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

7 July 2018

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047400

21 January 2018

Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047400

21 January 2018

Impact of HIV Infection on the Recurrence of Tuberculosis in South India

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047400

21 January 2018

Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

27 October 2018

Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3522661

27 October 2018

Risk of development of tuberculosis in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculin skin test results in HIV-infected patients in India: implications for latent tuberculosis treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23251327

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0047400

1 reference

Europe PubMed Central

2 August 2017

2012PLoSO...747400S

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34515554&oldid=2139657419"